Do changes in SSEP amplitude over time predict the outcome of comatose survivors of cardiac arrest?

Cardiac arrest Coma Hypoxic-Ischaemic Brain Injury (HIBI) Prognosis Short-latency Somatosensory Evoked Potentials (SSEPs)

Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
12 2022
Historique:
received: 19 08 2022
revised: 28 10 2022
accepted: 30 10 2022
pubmed: 15 11 2022
medline: 17 12 2022
entrez: 14 11 2022
Statut: ppublish

Résumé

To assess if the amplitude of the N20 wave (N20Amp) of somatosensory evoked potentials (SSEPs) changes between 12-24 h and 72 h from the return of spontaneous circulation (ROSC) after cardiac arrest and if an N20Amp decrease predicts poor neurological outcome (CPC 3-5) at six months. Retrospective analysis of the ProNeCA multicentre prognostication study dataset. (NCT03849911). In adult comatose cardiac arrest survivors whose SSEPs were recorded at both 12-24 h and 72 h after ROSC, we measured the median N20Amp at each timepoint and the individual change in N20Amp across the two timepoints. We identified their cutoffs for predicting poor outcome with 0% false positive rate (FPR) and compared their sensitivities. We included 236 patients. The median [IQR] N20Amp increased from 1.90 [0.78-4.22] µV to 2.86 [1.52-5.10] µV between 12-24 h and 72 h (p = 0.0019). The N20Amp cutoff for 0% FPR increased from 0.6 µV at 12-24 h to 1.23 µV at 72 h, and its sensitivity increased from 56[48-64]% to 71[63-77]%. Between 12-24 h and 72 h, an N20Amp decrease > 53% predicted poor outcome with 0[0-5]% FPR and 26[19-35]% sensitivity. Its combination with an N20Amp < 1.23 µV at 72 h increased sensitivity by 1% to 72[64-79]%. In comatose cardiac arrest survivors, the median N20Amp and its cutoff for predicting poor neurological outcome increase between 12-24 and 72 h after ROSC. An N20Amp decrease greater than 53% between these two timepoints predicts poor outcome with 0% FPR, confirming the unfavourable prognostic signal of a low N20Amp at 72 h.

Identifiants

pubmed: 36375653
pii: S0300-9572(22)00705-5
doi: 10.1016/j.resuscitation.2022.10.025
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03849911']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-139

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Maenia Scarpino (M)

IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy.

Francesco Lolli (F)

Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università degli studi di Firenze, Italy.

Giovanni Lanzo (G)

SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy.

Riccardo Carrai (R)

IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy.

Maddalena Spalletti (M)

IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy.

Franco Valzania (F)

UO Neurofisiopatologia Arcispedale. Santa Maria Nuova, Reggio nell'Emilia, Italy.

Maria Lombardi (M)

UO Neurologia, Ospedale San Giuseppe, Empoli, Italy.

Daniela Audenino (D)

SC Neurologia, Ospedale Galliera, Genoa, Italy.

Sara Contardi (S)

Neurofisiopatologia Interventiva, Osp Civile di Baggiovara, Modena, Italy.

Maria Grazia Celani (M)

UO Neurofisiopatologia, Ospedale Santa Maria della Misericordia, Perugia, Italy.

Alfonso Marrelli (A)

UOC Neurofisiopatologia, Ospedale San Salvatore, L'Aquila, Italy.

Oriano Mecarelli (O)

UOC Neurofisiopatologia, Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome, Italy.

Chiara Minardi (C)

UO Neurologia, Ospedale Bufalini, Cesena, Italy.

Fabio Minicucci (F)

UO Neurofisiopatologia, Ospedale San Raffaele IRCCS, Milan, Italy.

Lucia Politini (L)

Ospedale Civile, Legnano, Italy.

Eugenio Vitelli (E)

Ospedale Maggiore, Lodi, Italy.

Adriano Peris (A)

SODc Cure intensive per il trauma ed i supporti extracorporei, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy.

Aldo Amantini (A)

IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy.

Antonello Grippo (A)

IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy; SODc Neurofisiopatologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy.

Claudio Sandroni (C)

Department of Intensive Care, Emergency Medicine and Anaesthesiology, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy; Institute of Anaesthesiology and Intensive Care Medicine, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: claudio.sandroni@policlinicogemelli.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH